Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;74(6):971-7.
doi: 10.1111/j.1365-2125.2012.04292.x.

Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis

Naïm Bouazza  1 , Vincent Pestre, Vincent Jullien, Emmanuel Curis, Saïk Urien, Dominique Salmon, Jean-Marc Tréluyer
Affiliations

Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis

Naïm Bouazza et al. Br J Clin Pharmacol. 2012 Dec.

Abstract

Aims: This study was performed to describe clindamycin, administered either orally or intravenously, concentration-time courses to patients with osteomyelitis, to study the effects of different covariates on clindamycin pharmacokinetics and to simulate an optimized administration scheme.

Methods: Clindamycin concentrations were measured in 50 patients. A total of 122 plasma concentrations were available (58 from oral administration and 64 from i.v. infusion). A population pharmacokinetic model was developed with MONOLIX 4 software.

Results: A one compartment model adequately described the data. Clindamycin clearance increased significantly with body weight (BW). The typical population estimates (interindividual variability) for clearance, volume of distribution and absorption rate constant were 16.2 l h(-1) (0.39), 70.2 l and 0.92 h(-1) , respectively. The bioavailability of the oral form was estimated to be 87.6%. According to BW, theoretical doses needed to reach a C(min) of 2 mg l(-1) were then calculated.

Conclusions: The current recommendation of 600 mg three times daily seems to be effective up to 75 kg but the dose should be raised to 900 mg three times daily thereafter. These assumptions should be prospectively confirmed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Observed plasma clindamycin concentrations (closed circles) and population pharmacokinetic based model-predicted clindamycin concentrations (curve) as a function of time for i.v. infusion (black) and oral dosing (blue)
Figure 2
Figure 2
PC-VPC (prediction-corrected visual predictive check) for clindamycin concentrations A) after i.v. administration and B) after oral dosing. The green lines show the 10th, 50th and 90th percentiles of observed data; the areas represent the 90% confidence interval around the simulated percentiles
Figure 3
Figure 3
Diagnostic plots: population weighted residuals (WRES) (A, C) and normalized prediction distribution error (NPDE) (B, D) as a function of time (A, B) and population prediction (C, D)
Figure 4
Figure 4
Dose (mg 8 h−1) needed to achieve a target minimum concentration of 2 mg l−1 for clindamycin as a function of body weight. Dashed lines correspond to 90% confidence interval. Horizontal green line correspond to the usual dose of 600 mg every 8 h
See this image and copyright information in PMC

References

    1. Lazzarini L, Lalla F, de, Mader JT. Long bone osteomyelitis. Curr Infect Dis Rep. 2002;4:439–45. - PubMed
    1. Lazzarini L, Lipsky BA, Mader JT. Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials? Int J Infect Dis. 2005;9:127–38. - PubMed
    1. Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases. 5th edn. Philadelphia, PA: Churchill Livingstone; 2000. on CD-ROM. 5th éd.
    1. Dornbusch K, Carlström A, Hugo H, Lidströlm A. Antibacterial activity of clindamycin and lincomycin in human bone. J Antimicrob Chemother. 1977;3:153–60. - PubMed
    1. Panzer JD, Brown DC, Epstein WL, Lipson RL, Mahaffey HW, Atkinson WH. Clindamycin levels in various body tissues and fluids. J Clin Pharmacol. 1972;12:259–62. - PubMed

MeSH terms